Sailis Medical

Sailis Medical Technology Group Co., Ltd. (Stock Code: 603716), founded in February 2004, is headquartered in Wuhan, Hubei Province, with a self-owned industrial park of 27,000 square meters. The company successfully entered the capital market in October 2016, becoming the first medical intensive operation service provider listed on the Shanghai Stock Exchange main board in Central China, and a pioneer in lean management of hospitals and the new ecosystem of smart healthcare in the industry. In 2020, Sailis Medical established its headquarters in Shanghai, initiating a dual-headquarters strategy, leveraging Shanghai's advantages as an innovation center in biotechnology, smart healthcare innovation talent, and business environment, to focus on smart healthcare and seize the opportunities in the big health industry, accelerating the domestic substitution of innovative diagnostic technologies and consumables/reagents. The company promotes the upgrading of the health industry under the trend of smart healthcare driven by IoT, big data, and AI. Through measures such as technology enablement, business synergy, and strategic investment, with "service innovation" as the core and "technology leadership" as the future, Sailis Medical empowers traditional medical services to transform and upgrade towards lean and intelligent operations using information technologies such as big data, blockchain, cloud computing, IoT, and AI. Meanwhile, it strengthens industrial collaboration, integrating regional testing center co-construction, SPD lean management, and IVD intensive systems, and extends to out-of-hospital patient care scenarios such as "PBM pharmacy benefit management," "Home medical HaD," and "Chronic disease co-insurance and long-term care insurance," building a "technology-enabled" full-lifecycle health service platform spanning in-hospital drugs and consumables, out-of-hospital patient care, and insurance reimbursement. As an SPD intensive service operator, it provides medical institutions with one-stop services including centralized procurement of medical consumables, distribution, inventory management, centralized settlement, department operation performance analysis, and supply chain finance. As an IVD intensive service operator, it offers professional services regarding IVD centralized procurement, supply and distribution, equipment maintenance, information construction, and ISO15189 certification support, helping medical institutions reduce costs and improve efficiency. It cooperates in co-building regional testing centers, undertaking laboratory main construction, information construction, specimen logistics, and external specimen testing, achieving mutual recognition of test results within the same region, and creating win-win outcomes for the government, hospitals, and patients. For proprietary brand product R&D, it innovates for a healthy China, improves layout, introduces global technologies, and provides clinical testing institutions with higher quality and more comprehensive testing products. Comprehensive compensation and benefits: 1. Basic salary, performance salary, year-end bonus; 2. Social insurance (pension, medical, unemployment, maternity, work-related injury) and housing fund; 3. Five-day, eight-hour work system; labor contract signed; 4. Paid annual leave; 5. Marriage leave, sick leave, etc., with condolence gift money and holiday benefits from the company; 6. Diversified employee training; 7. Compliance with national statutory holidays; 8. Complete promotion channels and internal promotion/competition mechanisms. Company address: No. 1310, Jinshan Avenue, Dongxihu District, Wuhan, Hubei Province. Enterprise email: hr@*